Crossmark

p53 and Ki-67 combined with periodic acid-Schiff staining for the diagnosis of early stage esophageal squamous cell carcinoma lesions in biopsy specimens

Crossref DOI link: https://doi.org/10.1007/s10388-024-01102-7

Published Online: 2024-12-23

Published Print: 2025-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Feifei

Zhao, Hongying

Li, Xue
License Information

Text and Data Mining valid from 2024-12-23

Version of Record valid from 2024-12-23
More Information

Article History

Received: 3 April 2024

Accepted: 9 December 2024

First Online: 23 December 2024

Declarations

:

: The authors declare no competing interests.

: The study was conducted in accordance with the Declaration of Helsinki and was approved by the ethics committee of Beijing Chao-Yang Hospital (No. 2023–598). Since this was a retrospective study and involved no direct patient intervention, informed consent was waived. However, all patient data were anonymized, and confidentiality was maintained throughout the study.

Document is current

Any future updates will be listed below